One Shot™ BL21(DE3) Chemically Competent E. coli
One Shot&trade; BL21(DE3) Chemically Competent <i>E. coli</i>
Invitrogen™

One Shot™ BL21(DE3) Chemically Competent E. coli

One Shot™ BL21(DE3)ケミカルコンピテント大腸菌は、バクテリオファージ T7 プロモーターベースの発現システム(pRSET、PCR™T7詳細を見る
製品番号(カタログ番号)数量
C60000320x50 μL
製品番号(カタログ番号) C600003
価格(JPY)
81,300
Each
お問い合わせください ›
数量:
20x50 μL
One Shot™ BL21(DE3)ケミカルコンピテント大腸菌は、バクテリオファージ T7 プロモーターベースの発現システム(pRSET、PCR™T7、および PET など)での使用に最適です。BL21(DE3)細胞は、lambda DE3 lysogen を運びます。大腸菌に毒性 のない組換えタンパク質は、BL21(DE3) pLysS または BL21(DE3) pLysE よりも BL21(DE3)細胞において高いレベルで一般的に発現されます。しかし、BL21(DE3) pLysS や BL21(DE3) pLysE よりも、異種遺伝子の基礎発現レベルは有意に高くなっています。

BL21 株について。
BL21 株は大腸菌 B 株に由来し、組換えタンパク質の高レベル発現用に特別に構築されています。これらの菌株は、タンパク質発現に最適な 2 つの重要な特性を持っています。重要な遺伝子マーカーとタンパク質発現の誘導性です。最も重要な遺伝子マーカーは、組換え RNA および / またはタンパク質が分解することなく高レベルに蓄積するのに役立ちます。Inducibility は、一部の組換えタンパク質の毒性の影響を最小限に抑えるのに役立ちます。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
抗生物質耐性菌No
青/白スクリーニング不可
メチル化DNAのクローニング不可
F'エピソームを含むF’エピソームが欠落しています
高スループット適合性ハイスループット非対応(手動)
プラスミドの品質を向上不可
Improves Protein StabilityYes (lon, ompT)
Improves RNA StabilityNo
非メチル化DNAの調製Yes (dcm)
製品ラインOne Shot
製品タイプコンピテントセル
数量20x50 μL
組換えを抑制不可
出荷条件Dry Ice
T1ファージ-耐性(tonA)不可
Toxic ProteinsNo
形質転換効率レベル中効率 (10^8-10^9 cfu⁄µg)
フォーマットOne Shot
プロモーターT7
E. coli
Unit SizeEach
組成および保存条件
内容:
• One Shot™ BL21(DE3)大腸菌:20 バイアル、各 50µ l(合計 1 ml)
• pUC19 DNA( 10 pg/ul):1 バイアル、50 µl
• SOC 培地:1本、6 ml

Competent Cellは-80℃で保存してください。pUC19 DNAは-20℃で保存してください。SOC培地は4℃または室温で保存してください。

よくあるご質問(FAQ)

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

引用および参考文献 (12)

引用および参考文献
Abstract
The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly.
Authors:Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H, Kleiman L,
Journal:J Biol Chem
PubMed ID:12756246
'Human lysyl-tRNA synthetase (LysRS) is a tRNA-binding protein that is selectively packaged into HIV-1 along with its cognate tRNALys isoacceptors. Evidence exists that Gag alone is sufficient for the incorporation of LysRS into virions. Herein, using both in vitro and in vivo methods, we begin to map regions in Gag ... More
The anti-trp RNA-binding attenuation protein (Anti-TRAP), AT, recognizes the tryptophan-activated RNA binding domain of the TRAP regulatory protein.
Authors: Valbuzzi Angela; Gollnick Paul; Babitzke Paul; Yanofsky Charles;
Journal:J Biol Chem
PubMed ID:11786553
'In Bacillus subtilis, the trp RNA-binding attenuation protein (TRAP) regulates expression of genes involved in tryptophan metabolism in response to the accumulation of l-tryptophan. Tryptophan-activated TRAP negatively regulates expression by binding to specific mRNA sequences and either promoting transcription termination or blocking translation initiation. Conversely, the accumulation of uncharged tRNA(Trp) ... More
The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.
Authors:Tokarz S, Berset C, La Rue J, Friedman K, Nakayama K, Nakayama K, Zhang DE, Lanker S,
Journal:J Biol Chem
PubMed ID:15342634
'The Skp2 oncoprotein belongs to the family of F-box proteins that function as substrate recognition factors for SCF (Skp1, cullin, F-box protein) E3 ubiquitin-ligase complexes. Binding of the substrate to the SCFSkp2 complex catalyzes the conjugation of ubiquitin molecules to the bound substrate, resulting in multi-ubiquitination and rapid degradation by ... More
A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci.
Authors:Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF.
Journal:Science
PubMed ID:11239156
beta-Lactamase and penicillin-binding protein 2a mediate staphylococcal resistance to beta-lactam antibiotics, which are otherwise highly clinically effective. Production of these inducible proteins is regulated by a signal-transducing integral membrane protein and a transcriptional repressor. The signal transducer is a fusion protein with penicillin-binding and zinc metalloprotease domains. The signal for ... More
The solution structure and interactions of CheW from Thermotoga maritima.
Authors: Griswold Ian J; Zhou Hongjun; Matison Mikenzie; Swanson Ronald V; McIntosh Lawrence P; Simon Melvin I; Dahlquist Frederick W;
Journal:Nat Struct Biol
PubMed ID:11799399
Using protein from the hyperthermophile Thermotoga maritima, we have determined the solution structure of CheW, an essential component in the formation of the bacterial chemotaxis signaling complex. The overall fold is similar to the regulatory domain of the chemotaxis kinase CheA. In addition, interactions of CheW with CheA were monitored ... More